Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,515.00p
   
  • Change Today:
    -100.00p
  • 52 Week High: 2,715.00p
  • 52 Week Low: 1,424.00p
  • Currency: UK Pounds
  • Shares Issued: 66.54m
  • Volume: 101,032
  • Market Cap: £1,673.42m
  • RiskGrade: 128
  • Beta: 0.03

Deal with Barclays    Trade now with Barclays Stockbrokers

Regulatory News

Director/PDMR Shareholding 11-Sep-2025 12:20 RNS
Additional Listing 08-Sep-2025 16:05 RNS
Preliminary results 04-Sep-2025 07:00 RNS
Accelerated Chinese porcine JV formation 04-Sep-2025 07:00 RNS
Notification of Major Holdings 28-Aug-2025 16:57 RNS
Notification of Major Holdings 19-Aug-2025 15:03 RNS
Notification of Major Holdings 19-Aug-2025 07:00 RNS
Holding(s) in Company 06-Aug-2025 10:51 Business Wire
Notification of Major Holdings 04-Aug-2025 11:14 RNS
Block Listing Six Monthly Return 01-Aug-2025 10:10 RNS
Total Voting Rights 01-Aug-2025 10:05 RNS
FY25 Trading Update 15-Jul-2025 07:00 RNS
Appointment of Financial Adviser & joint Broker 09-May-2025 09:25 RNS
Total Voting Rights 01-May-2025 14:28 RNS
PRRS Resistant Pig – FDA Approval 30-Apr-2025 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,515.00p
Change Today -100.00p
% Change -3.82 %
52 Week High 2,715.00p
52 Week Low 1,424.00p
Volume 101,032
Shares Issued 66.54m
Market Cap £1,673.42m
Beta 0.03
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Income
98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 1
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 06-Nov-25 06-Mar-25
Paid 05-Dec-25 04-Apr-25
Amount 21.70p 10.30p

Trades for 15-Sep-2025

Time Volume / Share Price
16:36 12,161 @ 2,515.00p
16:36 2,974 @ 2,515.00p
16:35 261 @ 2,515.00p
16:35 97 @ 2,515.00p
16:35 43,156 @ 2,515.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page